Myelodysplastic syndromes trials in Germany

3 of 28 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms

  Where

  Mainz

  Age

  18 years and over

  People

  190

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07752121
• No phaseNot yet taking people in Germany
  Dresden MDS Registry With an Accompanying Biomaterial Collection

  Where

  Dresden

  Age

  18 years and over

  People

  500

  Run by

  Technische Universität Dresden

  See details and how to joinNCT07561385
• No phaseTaking people
  Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood

  Where

  Freiburg im Breisgau

  Age

  Up to 17 years

  People

  260

  Run by

  University Hospital Freiburg

  See details and how to joinNCT00662090